|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/127 | |
| A61P 35/00 | |||
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61K 9/19 | |||
| A61K 9/00 | |||
| A61K 47/24 | |||
| A61K 33/24 |
| (11) | Patento numeris | 3400072 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17736515.2 |
| Europos patento paraiškos padavimo data | 2017-01-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/012720 |
| Data | 2017-01-09 |
| (87) | Numeris | WO 2017/120586 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 201662275936 P | 2016-01-07 | US | |
| 201662275941 P | 2016-01-07 | US | |
| 201662421137 P | 2016-11-11 | US |
| (72) |
BETAGERI, Guru, V., US
VENKATESAN, Natarajan, IN
OEFELEIN, Michael, G., US
THIRUCOTE, Ramachandran, US
SWARNAKAR, Nitin Kumar, US
HONG Teresa, US
|
| (73) |
Western University Of Health Sciences,
309 E. Second Street, Pomona, CA 91766,
US
Tesorx Pharma, LLC, 325 Sharon Park Drive, Suite 739, Menlo Park, CA 94025, US |
| (54) | FORMULATIONS FOR TREATING BLADDER CANCER |
| FORMULATIONS FOR TREATING BLADDER CANCER |